ERBB2 and ovarian cancer: We confirmed that HA@MOF@GSK-J1 intensely decreased JMJD3, MYCN, and HER2 levels; these genes are involved in epigenetic regulation, metastasis, and ovarian cancer tumor stemness (Figure 6C).